Absci ABSI
NASDAQ ABSI
$10.14 +0.65 (+6.85%)
At close: Sep 29, 2026 · 4:00 PM EDT

Absci (ABSI) Revenue (2020 - 2026)

Updated

Absci's Revenue was $318,000 in Q2 2026, down 46.4% from $593,000 a year earlier but up 47.9% from the prior quarter.

Analysis

Absci (ABSI) Revenue (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Absci's Revenue was $1.56 million through Jun 30, 2026, down 62.3% year-over-year; for FY2025, it came in at $2.8 million, down 38.2% from FY2024.

  • Revenue has now declined for three consecutive years, with a five-year compound annual growth rate of -10.1% (FY2020 to FY2025).
  • In earlier years, Revenue was $4.53 million in FY2024 (-20.7%), $5.72 million in FY2023 (-0.5%), $5.75 million in FY2022 (+20.2%) and $4.78 million in FY2021 (unchanged).
  • Quarterly Revenue has moved between $215,000 (Q1 2026) and $3.37 million (Q2 2023) over five years.
  • Compared with a year earlier, Revenue has declined for five straight quarters, with an average decline of 0.6% over the last eight quarters.
  • The best year-over-year quarter for Revenue over five years was Q2 2023 (growth of 236.0%); the worst was Q1 2026 (a decline of 81.8%).
  • Per Business Quant data, ABSI's Revenue in the three quarters before Q2 2026 was $215,000 (Q1 2026), $650,000 (Q4 2025) and $378,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 25.31 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 16.99 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.38 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 7.80 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.33 Bn
10 Absci 1.63 Bn 1.01 Bn - 318,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 318,000.00
Mar 31, 2026 215,000.00
Dec 31, 2025 650,000.00
Sep 30, 2025 378,000.00
Jun 30, 2025 593,000.00
Mar 31, 2025 1.18 Mn
Dec 31, 2024 665,000.00
Sep 30, 2024 1.70 Mn
Jun 30, 2024 1.27 Mn
Mar 31, 2024 898,000.00
Dec 31, 2023 338,000.00
Sep 30, 2023 744,000.00
Jun 30, 2023 3.37 Mn
Mar 31, 2023 1.27 Mn
Dec 31, 2022 1.56 Mn
Sep 30, 2022 2.37 Mn
Jun 30, 2022 1.00 Mn
Mar 31, 2022 819,000.00
Dec 31, 2021 1.45 Mn
Sep 30, 2021 1.54 Mn
API Access

Absci Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=ABSI&period=max&api_key=YOUR_API_KEY